OPKO Health to Present New Clinical Data on Rayaldee (ER Cal

MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) will present late-breaking clinical data on RAYALDEE® extended-release calcifediol (ERC) at the American Society of Nephrology (ASN) Kidney

Related Keywords

United States , Philadelphia , Pennsylvania , Miami , Florida , American , Charlesw Bishop , Akhtar Ashfaq , Lyvonne Briggs , Bruce Voss , Stephena Strugnell , Health Inc , Drug Administration , American Society Of Nephrology , Exchange Commission , American Society , Kidney Week , Secondary Hyperparathyroidism , Extended Release Calcifediol , Exhibit Hallsb D , Calcifediol Overcomes Impact , Mineral Metabolism , Exhibit Halls , Release Calcifediol , Data Journey , Real World Evidence Highlights , Early Treatment , Private Securities Litigation Reform Act , Annual Reports ,